The Duffy binding-like (DBL) domains are common adhesion modules present in Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants, which are responsible for immune evasion and cytoadherence. Knowledge about how immune responses are acquired against polymorphic DBL domains of PfEMP1 can aid in the development of vaccines for malaria. A recombinant DBL␣ domain, encoded by R29 var1, which binds complement receptor 1 to mediate rosetting by the P. falciparum laboratory strain R29, was expressed in Escherichia coli, renatured by oxidative refolding to its native form, and purified to homogeneity. Antibody levels in 704 plasmas obtained from residents of areas of different levels of malaria endemicity in Orissa (India) and Manhiça (Mozambique) were assessed by enzyme-linked immunosorbent assay. The refolded DBL␣ domain was pure, homogeneous, and functional in that it bound human erythrocytes with specificity and was capable of inhibiting rosetting. The proportion of individuals who had measurable anti-DBL␣ immunoglobulin G responses was low in areas of low malaria endemicity in Orissa (6.7%) but high in areas of high endemicity in Orissa (87.5%) and Manhiça (74.5%). Seroprevalence and antibody levels against the recombinant protein increased with the age of inhabitants from areas with high transmission rates (P < 0.001). Half of the children in these areas had seroconverted by the age of 5 years. These findings suggest that in spite of the extreme polymorphism of PfEMP1 DBL␣ domains, the acquisition of specific antibodies is rapid and age related and reflects the reduced risk of malaria in areas with high transmission rates. Further studies are required to elucidate the role of these antibodies in protection from malaria.
Individuals residing in areas where Plasmodium falciparum malaria is endemic gradually develop clinical immunity with age following repeated infections (17) . Passive transfer experiments have shown that immunoglobulin G (IgG) antibodies play a major role in the mechanisms of protection against malaria (9, 10) . Naturally acquired IgGs with specificity for variant surface antigens (VSA) expressed on the surfaces of P. falciparum-infected erythrocytes (IE) are believed to contribute to the regulation of parasite densities in a manner that decreases the incidence of clinical disease (4, 13, 15, 19) .
The most studied VSA, P. falciparum erythrocyte membrane protein 1 (PfEMP1), is a family of large (ϳ250 to 350 kDa) (2) , polymorphic proteins that are encoded in each parasite genome by ϳ60 different var genes (12) . Switches in var gene expression allow parasites to evade host immunity (18) .
PfEMP1 mediates the binding of IE to host endothelial cell receptors, to uninfected erythrocytes to mediate rosetting, and to platelets to form clumps of IE enabling sequestration of the parasite at different sites in the host (21) . Sequestration in some internal organs has been implicated in progression to severe disease manifestations, such as cerebral and placental malaria (23) .
PfEMP1 proteins are composed of a variable number of adhesive domains of two types, namely, Duffy binding-like (DBL) domains and cysteine-rich interdomain regions (34) . DBL sequences are extremely polymorphic, probably reflecting the intensity of immune pressure on PfEMP1 proteins at the IE surface. Although these domains average Ͻ50% amino acid identity (11) , they can still be classified into six different types (␣, ␤, ␥, ␦, ε, and X) based on the presence of conserved sequence motifs, including disulfide-linked cysteines (34) . Certain DBL␣ domains harbor adhesive functions associated with virulent phenotypes. It has been shown that the DBL␣ domain is involved in the formation of rosettes (7, 31) , a cytoadhesion phenotype that is associated with cerebral malaria (5, 23, 30, 36) . The DBL␣ domain encoded by R29 var1, the var gene expressed by the rosetting parasite R29, binds complement receptor 1 (CR1) on erythrocytes to mediate the formation of rosettes (31) . The CR1 binding residues map to the 233-aminoacid central stretch of the DBL␣ domain (20) .
Current research efforts seek to determine whether specific PfEMP1 variants containing related adhesive domains with conserved structures are associated with severe disease. Such conserved adhesion-related protein structures could then be targeted therapeutically or prophylactically across parasite isolates to protect against severe malaria. The association between naturally acquired antibodies against VSA (4, 13, 19) , which are dominantly represented by PfEMP1 molecules, and protection against clinical malaria in regions of endemicity argues for the inclusion of PfEMP1 domains in the development of malaria vaccines. Despite this apparent role in the development of antimalarial immunity, the use of PfEMP1 in vaccine development is hampered by the extensive polymorphism in the var gene family. Nevertheless, evidence supporting the utilization of the DBL␣ domain as a vaccine candidate is accumulating (8, 22) . DBL␣ is an attractive candidate because it is one of the most conserved domains of PfEMP1 (11) . Understanding naturally acquired immune responses to DBL␣ can aid in the development of malaria vaccines based on this domain.
Here we describe methods to produce the central, functional region of the R29 var1-encoded DBL␣ domain in its correctly folded conformation. The recombinant DBL␣ (rDBL␣) domain was used to assess the presence of naturally acquired anti-DBL␣ antibodies in plasma samples collected from individuals residing in areas of different levels of endemicity in India and Mozambique. We show that individuals from areas with high rates of malaria transmission rapidly develop antibodies against DBL␣ as a function of age.
MATERIALS AND METHODS

Expression of rDBL␣.
The binding site of the R29 var1-encoded DBL␣ domain has been mapped to the central region including amino acids 133 to 366 (Cys residues 5 to 12) (20) . A DNA fragment (nucleotides 399 to 1098) encoding R29 DBL␣ (20, 31) fused to a hexahistidine tag at the C-terminal end was amplified by a PCR using primers 5Ј-GCA TGC CAT GGA TAG AAA TTT  AGA ATA TTT GAT C-3Ј and 5Ј-CGA GTG TCG ACT CAG TGA TGG TGA  TGG TGA TGA CGT GGA CAA TTT AAA TCT ATA AAG-3Ј , with a plasmid containing a DNA fragment encoding DBL␣ of P. falciparum R29 as the template. The PCR product was cloned into Escherichia coli expression vector pET28a(ϩ) (Novagen). The insert as well as junctions between the vector and insert was sequenced using an ABI 310 automated DNA sequencer (Applied Biosystems). E. coli BL21(DE3) cells (Novagen) were transformed with the construct and used for expression of rDBL␣ by induction with 1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). After 4 h of growth at 37°C, E. coli cells were harvested and lysed by sonication, and inclusion bodies were collected by centrifugation and solubilized in 10 mM Tris, pH 8.0, containing 6 M guanidinehydrochloride. rDBL␣ was purified from solubilized inclusion bodies under denaturing conditions by metal-affinity chromatography using a nickel-nitrilotriacetic acid column as described by the manufacturer (Qiagen). The column was washed with equilibration buffer at pH 6.3, and bound protein was eluted with elution buffer at pH 4.3.
Refolding of rDBL␣. Purified, denatured rDBL␣ was refolded by 100-fold dilution in a buffer containing 50 mM phosphate buffer, pH 6.5, 2 mM cysteine, 0.67 mM cystamine dihydrochloride, 16 mM ␤-cyclodextrin, 0.4 mM Triton X-100, 1 M urea, and 0.5 M arginine at a final concentration of recombinant protein of 60 mg/ml. Refolding was allowed to proceed for 36 h at 10°C. The refolding solution was dialyzed for 48 h against dialysis buffer (50 mM phosphate buffer, pH 6, 1 M urea) to remove arginine. Refolded rDBL␣ was loaded on an SP-Sepharose column (Pharmacia) equilibrated with 50 mM phosphate buffer, pH 6, and the bound protein was eluted with a linear gradient of NaCl (100 mM NaCl to 1 M NaCl). Fractions containing refolded rDBL␣ were pooled, and rDBL␣ was further purified by gel filtration chromatography using a preparativegrade Superdex 75 column (Pharmacia) with 50 mM phosphate buffer, pH 6.0, containing 150 mM NaCl as the running buffer. Refolded rDBL␣ was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) before and after reduction with ␤-mercaptoethanol and was detected by Coomassie blue and silver staining.
Analysis of refolded rDBL␣ by reverse-phase chromatography. Refolded rDBL␣ was loaded on a reverse-phase C 8 column. The gradient used for elution was developed using buffer A (0.05% trifluoroacetic acid in water) and buffer B (0.05% trifluoroacetic acid in 90% acetonitrile and 10% water). The column was initially equilibrated with 95% buffer A and 5% buffer B and reached a composition of 90% buffer A and 10% buffer B in 10 min and a final composition of 5% buffer A and 95% buffer B in another 30 min.
Functional characterization of refolded rDBL␣. Blood collected in 10% citrate phosphate dextrose was washed three times in RPMI 1640. Ten micrograms of rDBL␣ was incubated for 1 h at room temperature with 2 ϫ 10 8 normal erythrocytes or human erythrocytes expressing low levels of CR1 (kindly provided by Karina Yazdanbaksh, New York Blood Centre, New York, NY) in a final volume of 600 l of RPMI 1640 containing 1% fetal calf serum. The reaction mixture was layered over dibutylphthalate (Sigma) and centrifuged to collect erythrocytes. Bound protein was eluted from the erythrocytes with 300 mM NaCl, separated by SDS-PAGE, and detected by Western blotting using a mouse monoclonal antibody against pentahistidine (Qiagen). Plasmodium vivax region II (PvRII) of the Duffy binding protein, which was previously shown to bind Duffy antigen receptor for chemokines on erythrocytes by this method (33) , was used as a positive control. The intensities of the bands were quantified by densitometry scanning.
Rosette reversal by rDBL␣. A P. falciparum R29 culture at 5% parasitemia and with a rosetting frequency of 60 to 70% was stained with 20 g/ml ethidium bromide for 5 min at 37°C, washed twice with incomplete RPMI 1640, and resuspended at 4% hematocrit in complete RPMI with 10% heat-inactivated human serum. Twenty-five microliters of parasite suspension was incubated at 37°C for 30 min with doubling concentrations of rDBL␣ (0.4 g/ml to 200 g/ml) in a final volume of 50 l. The frequency of rosette formation was assessed by fluorescence microscopy in triplicate experiments. Two hundred infected erythrocytes were counted in each experiment, with the binding of two or more uninfected erythrocytes constituting a rosette. Rosetting at each rDBL␣ concentration was expressed as a percentage of the rosetting frequency in control R29 cultures with no added protein. The same amounts of PvRII were used as a negative control.
Study areas and subjects. Individuals were enrolled for the study at Sundargarh District in Orissa (Eastern India) in March 2004 and at Manhiça District (Southern Mozambique) in 2007. The characteristics of the areas have been described in detail elsewhere (16, 32) . Briefly, Sundargarh District is characterized by variations in transmission patterns over short geographic distances. The annual incidence of malaria cases per 1,000 persons is higher in villages located in forested areas (284.1) than in villages located in deforested plain areas (31. 
RESULTS
Biochemical, biophysical, and functional characterization of refolded and purified rDBL␣. rDBL␣ expressed in E. coli accumulates in inclusion bodies as insoluble aggregates. Misfolded rDBL␣ was solubilized in 6 M guanidine-HCl, purified under denaturing conditions by metal-affinity chromatography, and refolded by the method of rapid dilution. Cysteine and cystamine were used to allow disulfide bond shuffling during refolding. Conditions such as the concentration of rDBL␣ and pH were optimized to maximize yields of refolded rDBL␣. Ion-exchange chromatography using an SP-Sepharose column and gel filtration chromatography using a Superdex 75 column were used to purify rDBL␣ monomers to homogeneity after they refolded. rDBL␣ was separated by SDS-PAGE and detected by Coomassie blue (Fig. 1A) and silver (Fig. 1B) staining. rDBL␣ migrated with an apparent molecular mass of Ϸ27 kDa in denaturing SDS-PAGE gels, as predicted by the calculated molecular mass of DBL␣. Densitometry scanning of silver-stained SDS-PAGE gels indicated that the purity of refolded rDBL␣ was Ͼ95%. Refolded rDBL␣ migrated slower in SDS-PAGE gels after reduction with ␤-mercaptoethanol, indicating the presence of disulfide bonds (Fig. 1A) . The mobility of purified rDBL␣ in a Superdex 75 column was consistent with an apparent molecular mass of Ϸ27 kDa (data not shown), indicating that purified rDBL␣ does not contain aggregates or multimers. Refolded rDBL␣ eluted in a single, symmetric peak by reverse-phase chromatography on a C 8 column, suggesting that purified rDBL␣ is conformationally homogeneous (Fig. 1C) .
Erythrocyte binding assays were used to test the functional activity of refolded rDBL␣. After incubation of refolded rDBL␣ with normal or CR1-deficient human erythrocytes to allow binding, bound protein was eluted, separated by SDS-PAGE, and detected by Western blotting using a monoclonal antibody against pentahistidine (Fig. 2) . Refolded rDBL␣ bound to normal human erythrocytes. Densitometry scanning showed that binding of rDBL␣ to CR1-deficient erythrocytes was reduced 60% compared to binding to normal erythrocytes, whereas binding of PvRII to normal and CR1-deficient erythrocytes was similar (Fig. 2) .
FIG. 1. Refolded and purified rDBL␣ minimal domain. (A)
Mobility of refolded and purified DBL␣ by SDS-PAGE before and after reduction with ␤-mercaptoethanol (␤-ME). (B) Silver-stained SDS-PAGE gel of refolded and purified rDBL␣. Different quantities (0.5, 1.0, 1.5, and 2.0 g) of refolded and purified rDBL␣ were reduced, denatured, separated by SDS-PAGE, and detected by silver staining. (C) Reverse-phase chromatography profile of refolded and purified rDBL␣.
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The ability of rDBL␣ to reverse rosetting of P. falciparum R29 was also tested. rDBL␣ reversed rosetting of P. falciparum R29 in a dose-dependent manner (Fig. 3) . The rosetting frequency in the absence of rDBL␣ was 58% (standard deviation, 3%), whereas the rosetting frequency in the presence of 200 g/ml of rDBL␣ was 11.3% (standard deviation, 3.1%). Differences in rosetting frequency were statistically significant between control parasites with no added protein and parasites incubated with a minimum of 6.25 g/ml rDBL␣ (P Ͻ 0.01). No statistically significant reversal of rosetting was observed with similar amounts of PvRII (Fig. 3) .
Recognition of rDBL␣ by plasmas from individuals residing in areas where P. falciparum is endemic. There were marked differences among the three study areas with respect to the proportion of individuals who had measurable anti-rDBL␣ IgG responses (Table 1) . Seropositivity for rDBL␣ was significantly higher for residents in the forest villages of the Sundargarh District in Orissa (380/434 samples; 87.5%) than for residents in deforested plain areas of the Sundargarh District (7/105 samples; 6.7%) with lower malaria transmission rates (P Ͻ 0.001). Similarly, the level of anti-rDBL␣ IgGs was higher for the population from forest areas in Orissa than for those in plain villages (Fig. 4) (P Ͻ 0.001). In plain villages, no statistically significant difference between age groups was observed in recognition of rDBL␣ (Table 1 ) or in the level of IgGs (Fig.  4) . However, in the population from forest villages, rDBL␣ IgG seroprevalence (Table 1 ) and levels of antibodies (Fig. 4) increased with age. Compared to the youngest children (1 to 2.5 years), the prevalence of rDBL␣ IgG was similar for 2.5-to 5-year-old children (P ϭ 0.371) and increased significantly in 5-to 7.5-year-old children (P ϭ 0.018). In Manhiça (Mozambique), average recognition was 74.5% (123/165 samples) for rDBL␣, 53.9% (89/165 samples) for MSP-1, 59.3% (98/165 samples) for EBA-175, and 84.8% (140/165 samples) for AMA-1 ( Table 1 ). The prevalence of seropositive individuals (Table 1 ) and the level of antibodies (Fig. 5) were found to increase with age for rDBL␣, EBA-175, and AMA-1 but not for MSP-1 (Table 1; Fig. 5 ). Compared to the youngest children (1 to 2.5 years), the first significant increase in antibody levels was found at 2.5 to 5 years for rDBL␣ (P ϭ 0.004) and at 15 to 25 years for AMA-1 and EBA-175 (P Ͻ 0.001) (Fig. 5) . Similarly, seroprevalences for rDBL␣ were significantly higher in 2.5-to 5-year-old Mozambican children (53.3%) than in the youngest children (16.7%; P ϭ 0.006), whereas seroprevalences were found to increase later in life (15 to 25 years) for AMA-1 (P ϭ 0.001) and EBA-175 (P ϭ 0.003).
DISCUSSION
Here we report methods to produce the minimal functional domain of DBL␣ encoded by R29 var1 in its correctly folded conformation. Our results confirm that the region of DBL␣ required by P. falciparum R29 to mediate rosetting maps to the central 233-amino-acid region of DBL␣ encoded by R29 var1, which includes cysteines 5 to 12 (20) . Refolded E. coli DBL␣ is pure, homogeneous, and functional. First, the purity of DBL␣ was Ͼ95%, as determined by densitometry scanning of silverstained SDS-PAGE gels. Second, refolded E. coli DBL␣ eluted in a single peak during reverse-phase chromatography on a C 8 column, confirming that it was composed of a homogeneous population of conformers. Third, the migration profile of refolded DBL␣ by gel filtration chromatography indicates that it is monomeric. Fourth, DBL␣ exhibited a reduction-sensitive shift in mobility by SDS-PAGE, indicating that intramolecular disulfide bonds had formed. Fifth, rDBL␣ bound specifically to CR1, as CR1-deficient erythrocytes bound the recombinant protein less efficiently than normal erythrocytes did, indicating that rDBL␣ was folded in its functional conformation. Binding to CR1-deficient erythrocytes was not null, as the copy number of CR1 on CR1-deficient erythrocytes is ϳ10 to 20% that on normal erythrocytes (K. Yazdanbaksh, personal communication). Finally, we have shown that rDBL␣ is capable of reversing rosette formation in a dose-dependent manner. This is in contrast to a previous study (25) showing that bacterially produced DBL␣ domains were unable to disrupt rosettes. This discrepancy suggests that recombinant proteins produced through denaturation of inclusion bodies may not reflect the correct conformation and that methods to refold the recombinant protein are needed to obtain functional DBL domains (3, 33) . Recombinant refolded DBL␣ was recognized by plasmas from individuals residing in regions of India and Mozambique with high rates of malaria transmission, indicating that DBL␣ contains B-cell epitopes that are naturally exposed to the host immune system. In the Manhiça population, IgGs against MSP-1 were found to be the least seroprevalent (53.9%), followed by IgGs against EBA-175 (59.3%), DBL␣ (74.5%), and AMA-1 (84.8%). This is in the range of previously reported seroprevalences of IgGs against recombinant merozoite antigens (26) (27) (28) (29) and DBL␣ domains (24) in areas of malaria endemicity. Major differences in the acquisition of DBL␣-specific antibodies were observed between different malaria transmission settings. A significant proportion (75 to 87%) of individuals living in areas with high rates of malaria transmission in India (EIR, 110 infective bites per person per year) and Mozambique (EIR, 38 infective bites per person per year) had developed antibodies directed against DBL␣. However, residents of an area in India with a low rate of malaria transmission (EIR, 5 infective bites per person per year) showed poor recognition of rDBL␣ (seroprevalence of 6.7%). This is in accordance with a previous report (24) showing a strong correlation between the immune status of plasma donors and reactivity with rDBL␣ domains. In the areas with high rates of transmission, the proportion of rDBL␣ IgG-seropositive results increased significantly with age, similar to what was observed in Manhiça and other African settings for AMA-1 (35) and EBA-175 (27) but not for MSP-1 (26) . However, increases in IgGs during the first 5 years of life were more accentuated for DBL␣ than for AMA-1 and EBA-175, as only rDBL␣ IgG levels and prevalences were found to increase significantly during early childhood. Seroconversion against DBL␣ was found to occur later in the population from forest areas of Orissa (5 to 7.5 years) than in inhabitants from Manhiça (2.5 to 5 years), but this may have been due to the small number of young Indian children included in the study (n ϭ 23), which might have reduced the power of the comparisons. The age-related buildup of antibodies to DBL␣ in areas with high rates of transmission is presumably due to repeated exposure to infection by P. falciparum. It is interesting that the age at which children acquire antibodies against DBL␣ coincides with the age at which clinical immunity would be predicted to occur in Orissa forest areas (32) and Manhiça (14) . This suggests that antibodies to DBL␣ represent a marker of age-acquired immunity against P. falciparum. Our observations are in agreement with the concept of rapidly developing antibody responses against conserved epitopes in PfEMP1 DBL␣ domains in spite of their extreme polymorphism (24, 34) . The finding that one-half of the 2.5-to 5-yearold children from Mozambique recognized rDBL␣ suggests that they were exposed frequently, and possibly early in life, to parasites expressing PfEMP1 variants with epitopes similar to those contained in the recombinant protein. This may suggest that the R29 var1-encoded DBL␣ minimal domain contains conserved epitopes which transcend sequence diversity (6, 22, 24) . Whether antibodies targeting such epitopes of DBL␣ confer protection against P. falciparum malaria remains to be determined.
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